La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Meilleure Health International Industry Group Croissance future

Future contrôle des critères 0/6

Nous ne disposons actuellement pas d'une couverture d'analyste suffisante pour prévoir la croissance et les revenus de Meilleure Health International Industry Group.

Informations clés

n/a

Taux de croissance des bénéfices

n/a

Taux de croissance du BPA

Trade Distributors croissance des bénéfices	16.3%
Taux de croissance des recettes	n/a
Rendement futur des capitaux propres	n/a
Couverture par les analystes	None
Dernière mise à jour	n/a

Mises à jour récentes de la croissance future

Recent updates

Meilleure Health International Industry Group Limited's (HKG:2327) 31% Share Price Plunge Could Signal Some Risk

Jul 19

Meilleure Health International Industry Group (HKG:2327) Will Be Hoping To Turn Its Returns On Capital Around

Jun 17

Optimistic Investors Push Meilleure Health International Industry Group Limited (HKG:2327) Shares Up 32% But Growth Is Lacking

May 03

Meilleure Health International Industry Group's (HKG:2327) Earnings Are Of Questionable Quality

Apr 04

Some Confidence Is Lacking In Meilleure Health International Industry Group Limited (HKG:2327) As Shares Slide 30%

Feb 28

Returns Are Gaining Momentum At Meilleure Health International Industry Group (HKG:2327)

Jan 23

Returns At Meilleure Health International Industry Group (HKG:2327) Appear To Be Weighed Down

Aug 17

Investors Met With Slowing Returns on Capital At Meilleure Health International Industry Group (HKG:2327)

Oct 18

Is Meilleure Health International Industry Group (HKG:2327) A Risky Investment?

Sep 06

Investors Will Want Meilleure Health International Industry Group's (HKG:2327) Growth In ROCE To Persist

Jul 12

Does Meilleure Health International Industry Group (HKG:2327) Have A Healthy Balance Sheet?

Sep 09

Meilleure Health International Industry Group (HKG:2327) Shareholders Will Want The ROCE Trajectory To Continue

May 15

Meilleure Health International Industry Group (HKG:2327) Seems To Use Debt Rather Sparingly

Apr 18

Did You Miss Meilleure Health International Industry Group's (HKG:2327) Impressive 124% Share Price Gain?

Jan 29

Here's What We Think About Meilleure Health International Industry Group's (HKG:2327) CEO Pay

Dec 08

Dans cette section, nous présentons généralement des projections de croissance du chiffre d'affaires et des bénéfices basées sur les estimations consensuelles d'analystes professionnels afin d'aider les investisseurs à comprendre la capacité de l'entreprise à générer des bénéfices. Mais comme Meilleure Health International Industry Group n'a pas fourni suffisamment de données passées et n'a pas de prévisions d'analystes, ses bénéfices futurs ne peuvent pas être calculés de manière fiable en extrapolant les données passées ou en utilisant les prévisions des analystes.

Il s'agit d'une situation assez rare car 97% des entreprises couvertes par SimplyWall St disposent de données financières passées.

Prévisions de croissance des bénéfices et des revenus

SEHK:2327 - Estimations futures des analystes et données financières antérieures (HKD Millions )
Date	Recettes	Les revenus	Flux de trésorerie disponible	Cash from Op	Moy. Nombre d'analystes
12/31/2023	129	41	-137	-136	N/A
9/30/2023	130	33	-123	-122	N/A
6/30/2023	130	25	-109	-108	N/A
3/31/2023	125	22	-33	-32	N/A
12/31/2022	120	18	42	43	N/A
9/30/2022	148	23	42	46	N/A
6/30/2022	177	28	43	49	N/A
3/31/2022	215	44	-24	-17	N/A
12/31/2021	253	60	-90	-83	N/A
9/30/2021	263	72	-27	-24	N/A
6/30/2021	273	84	35	36	N/A
3/31/2021	269	84	53	53	N/A
12/31/2020	265	83	70	71	N/A
9/30/2020	262	32	11	11	N/A
6/30/2020	259	-19	-49	-48	N/A
3/31/2020	247	-19	-12	-12	N/A
12/31/2019	235	-20	25	25	N/A
9/30/2019	221	31	74	74	N/A
6/30/2019	208	83	123	123	N/A
3/31/2019	219	82	70	70	N/A
12/31/2018	231	81	18	18	N/A
9/30/2018	181	81	-40	-38	N/A
6/30/2018	132	81	-98	-94	N/A
3/31/2018	101	81	-83	-79	N/A
12/31/2017	69	80	-67	-63	N/A
9/30/2017	83	60	N/A	-177	N/A
6/30/2017	97	40	N/A	-291	N/A
3/31/2017	82	37	N/A	-276	N/A
12/31/2016	67	34	N/A	-261	N/A
12/31/2015	76	10	N/A	0	N/A
9/30/2015	17	-1	N/A	-45	N/A
6/30/2015	13	0	N/A	-21	N/A
3/31/2015	9	2	N/A	3	N/A
12/31/2014	16	1	N/A	29	N/A
9/30/2014	22	0	N/A	54	N/A
6/30/2014	29	44	N/A	63	N/A
3/31/2014	35	89	N/A	72	N/A
12/31/2013	34	87	N/A	47	N/A
9/30/2013	33	85	N/A	22	N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: Données insuffisantes pour déterminer si la croissance des bénéfices prévue de 2327 est supérieure au taux d'épargne ( 2.3% ).

Bénéfices vs marché: Données insuffisantes pour déterminer si les bénéfices de 2327 devraient croître plus rapidement que le marché Hong Kong

Croissance élevée des bénéfices: Données insuffisantes pour déterminer si les bénéfices de 2327 devraient augmenter de manière significative au cours des 3 prochaines années.

Chiffre d'affaires vs marché: Données insuffisantes pour déterminer si les revenus de 2327 devraient croître plus rapidement que le marché Hong Kong.

Croissance élevée des revenus: Données insuffisantes pour déterminer si les revenus de 2327 devraient croître plus rapidement que 20% par an.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: Données insuffisantes pour déterminer si le retour sur capitaux propres de 2327 devrait être élevé dans 3 ans

Meilleure Health International Industry Group Croissance future

Future contrôle des critères 0/6

Informations clés

Mises à jour récentes de la croissance future

Meilleure Health International Industry Group Limited Provides Consolidated Earnings Guidance for the Six Months Ended 30 June 2023

Recent updates

New minor risk - Share price stability

Meilleure Health International Industry Group Limited to Report First Half, 2024 Results on Aug 31, 2024

Meilleure Health International Industry Group Limited's (HKG:2327) 31% Share Price Plunge Could Signal Some Risk

Executive Co-Chairman of the Board recently bought HK$592k worth of stock

Meilleure Health International Industry Group (HKG:2327) Will Be Hoping To Turn Its Returns On Capital Around

Executive Co-Chairman of the Board recently bought HK$485k worth of stock

Optimistic Investors Push Meilleure Health International Industry Group Limited (HKG:2327) Shares Up 32% But Growth Is Lacking

Executive Co-Chairman of the Board recently bought HK$119k worth of stock

Meilleure Health International Industry Group Limited Announces Board and Committees Changes

Meilleure Health International Industry Group's (HKG:2327) Earnings Are Of Questionable Quality

Full year 2023 earnings released: EPS: HK$0.01 (vs HK$0.004 in FY 2022)

Dividend reduced to HK$0.004

Meilleure Health International Industry Group Limited, Annual General Meeting, Jun 27, 2024

Meilleure Health International Industry Group Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 20 August 2024

Meilleure Health International Industry Group Limited to Report Fiscal Year 2023 Final Results on Mar 28, 2024

Some Confidence Is Lacking In Meilleure Health International Industry Group Limited (HKG:2327) As Shares Slide 30%

Now 31% undervalued after recent price drop

Returns Are Gaining Momentum At Meilleure Health International Industry Group (HKG:2327)

Executive Co-Chairman of the Board recently bought HK$135k worth of stock

Executive Co-Chairman of the Board recently bought HK$133k worth of stock

Executive Co-Chairman of the Board recently bought HK$251k worth of stock

First half 2023 earnings released: EPS: HK$0.004 (vs HK$0.003 in 1H 2022)

New minor risk - Earnings quality

Returns At Meilleure Health International Industry Group (HKG:2327) Appear To Be Weighed Down

Meilleure Health International Industry Group Limited Provides Consolidated Earnings Guidance for the Six Months Ended 30 June 2023

Meilleure Health International Industry Group Limited to Report First Half, 2023 Results on Aug 31, 2023

Upcoming dividend of HK$0.016 per share at 5.4% yield

Executive Co-Chairman of the Board recently bought HK$274k worth of stock

Meilleure Health International Industry Group Limited Approves Final Dividend

Executive Co-Chairman of the Board recently bought HK$153k worth of stock

Executive Co-Chairman of the Board recently bought HK$145k worth of stock

Full year 2022 earnings released: EPS: HK$0.004 (vs HK$0.014 in FY 2021)

Executive Co-Chairman of the Board recently bought HK$1.1m worth of stock

Executive Co-Chairman of the Board recently bought HK$272k worth of stock

Executive Co-Chairman of the Board recently bought HK$325k worth of stock

Less than half of directors are independent

Executive Co-Chairman of the Board recently bought HK$169k worth of stock

Investors Met With Slowing Returns on Capital At Meilleure Health International Industry Group (HKG:2327)

Now 22% undervalued after recent price drop

Now 21% undervalued after recent price drop

Is Meilleure Health International Industry Group (HKG:2327) A Risky Investment?

First half 2022 earnings released: EPS: HK$0.003 (vs HK$0.01 in 1H 2021)

Meilleure Health International Industry Group Limited to Report First Half, 2022 Results on Aug 26, 2022

Investors Will Want Meilleure Health International Industry Group's (HKG:2327) Growth In ROCE To Persist

Meilleure Health International Industry Group Limited, Annual General Meeting, Jun 24, 2022

Less than half of directors are independent

Executive Co-Chairman of the Board recently bought HK$305k worth of stock

Full year 2021 earnings released: EPS: HK$0.014 (vs HK$0.02 in FY 2020)

Executive Co-Chairman of the Board recently bought HK$1.1m worth of stock

Independent Non-Executive Director recently sold HK$142k worth of stock

Does Meilleure Health International Industry Group (HKG:2327) Have A Healthy Balance Sheet?

First half 2021 earnings released: EPS HK$0.01 (vs HK$0.01 in 1H 2020)

Executive Co-Chairman of the Board recently bought HK$1.7m worth of stock

Meilleure Health International Industry Group (HKG:2327) Shareholders Will Want The ROCE Trajectory To Continue

Full year 2020 earnings released: EPS HK$0.02 (vs HK$0.005 loss in FY 2019)

Meilleure Health International Industry Group (HKG:2327) Seems To Use Debt Rather Sparingly

Executive Co-Chairman of the Board recently bought HK$441k worth of stock

Full year 2020 earnings released: EPS HK$0.02 (vs HK$0.005 loss in FY 2019)

Meilleure Health International Industry Group Limited to Report Fiscal Year 2020 Results on Mar 19, 2021

New 90-day high: HK$0.69

Did You Miss Meilleure Health International Industry Group's (HKG:2327) Impressive 124% Share Price Gain?

New 90-day high: HK$0.57

Executive Co-Chairman of the Board recently bought HK$1.5m worth of stock

Executive Co-Chairman of the Board recently bought HK$1.4m worth of stock

Executive Co-Chairman of the Board recently bought HK$870k worth of stock

Here's What We Think About Meilleure Health International Industry Group's (HKG:2327) CEO Pay

Yee Sheng Enterprises Company Limited entered into the Agreement to acquire Tech-Medi Development Limited from Meilleure Health International Industry Group Limited (SEHK:2327) for HKD 62.7 million.

Executive Co-Chairman of the Board recently bought HK$870k worth of stock

New 90-day high: HK$0.56

New 90-day high: HK$0.39

Executive Co-Chairman of the Board recently bought HK$630k worth of stock

Meilleure Health International Industry Group Limited (SEHK:2327) completed the acquisition of 8.3% stake in Shenzhen Gippro Innovation Limited from a natural person.

First half earnings released

Earnings released